Organogenesis Holdings (ORGO) Interest Coverage Ratio Growth (3y) (2019 - 2026)
Organogenesis Holdings (ORGO) Interest Coverage Ratio Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 241.78 Mn | 194.94 Mn | 20.08 Mn | 182.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,230.78% |
| Mar 31, 2026 | 651.01% |
| Dec 31, 2025 | 70.04% |
| Sep 30, 2025 | 313.98% |
| Jun 30, 2025 | -144.56% |
| Mar 31, 2025 | -238.12% |
| Dec 31, 2024 | -62.09% |
| Sep 30, 2024 | 99.70% |
| Jun 30, 2024 | -168.75% |
| Mar 31, 2024 | -28.07% |
| Dec 31, 2023 | -26.52% |
| Sep 30, 2023 | -74.11% |
| Jun 30, 2023 | 35.36% |
| Mar 31, 2023 | 58.48% |
| Dec 31, 2022 | -28.70% |
| Sep 30, 2022 | 28.25% |
| Jun 30, 2022 | 44.45% |
| Mar 31, 2022 | 72.94% |
| Dec 31, 2021 | 117.93% |
| Sep 30, 2021 | 27.43% |